We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
DYSPORT (Ispen Pty Ltd)
Product name
DYSPORT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
194 working days (255)
Active ingredients
clostridium botulinum type A toxin - haemagglutinin complex
Registration type
EOI
Indication
DYSPORT is now also indicated for the symptomatic treatment of:
- focal spasticity affecting the upper limbs in adults.
- focal spasticity affecting the lower limb in adults.
- lower limb focal spasticity in children aged 2 years of age or older.